Trademarkia Logo

Australia

AU$
AMYLYX
Protected: Registered/protected

Last updated on 28 Mar 2020

Owner Info

Amylyx Pharmaceuticals, Inc.

43 Thorndike Street

Cambridge MA 02141, UNITED STATES OF AMERICA

Serial Number

2041297 filed on 26 Aug 2019

Correspondent

Cynthia Johnson Walden Fish & Richardson P.C.

PO Box 10222,

Minneapolis MN 55440-1022,

UNITED STATES OF AMERICA

AMYLYX

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases.

Mark Details


Serial Number

2041297

Registered On

26 Aug 2019

Renewal On

26 Aug 2029

Mark Type

WORD

Priority Claim (Convention Details)


Date

28 Feb 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
28th Mar 2020International Registration in Australia Protected correspondence sent
27th Mar 2020IP Right Registration Published
27th Mar 2020Status change to Registered/Protected
21st Jan 2020Application Accepted correspondence sent
20th Jan 2020IP Right has been Examined
20th Jan 2020IP Right Acceptance Published
20th Jan 2020Status change to Accepted
3rd Oct 2019Awaiting examination
3rd Oct 2019Examination expedited
3rd Oct 2019IP Right Filed Published